東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

The aggregation and membrane permeab...

Volles, Michael James.

FindBook

Google Book

Amazon

博客來

The aggregation and membrane permeabilizing activity of alpha-synuclein.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	The aggregation and membrane permeabilizing activity of alpha-synuclein./
作者:	Volles, Michael James.
面頁冊數:	94 p.
附註:	Source: Dissertation Abstracts International, Volume: 65-01, Section: B, page: 0211.
Contained By:	Dissertation Abstracts International65-01B.
標題:	Chemistry, Biochemistry. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3118014
ISBN:	0496654381

The aggregation and membrane permeabilizing activity of alpha-synuclein.
Volles, Michael James.

The aggregation and membrane permeabilizing activity of alpha-synuclein. - 94 p.

Source: Dissertation Abstracts International, Volume: 65-01, Section: B, page: 0211.

Thesis (Ph.D.)--Harvard University, 2004.

Two point mutations in the alpha-synuclein gene are genetically linked to autosomal dominant Parkinson's disease. Purified monomeric alpha-synuclein protein is unfolded in solution, but over time a small mol fraction can aggregate to form a heterogeneous mixture of beta-sheet containing soluble oligomers (termed protofibrils) which coexist with the monomeric protein. The monomer/oligomer mixture eventually proceeds to form amyloid fibrils, at which time the majority of the monomer and oligomer is consumed. It is not known which aggregation form of alpha-synuclein is neurotoxic in Parkinson's disease, nor is the pathogenic mechanism known. This thesis demonstrates that a subset of the oligomeric species are capable of permeabilizing negatively charged synthetic phospholipid vesicles via a pore-like mechanism, in vitro. The monomeric and fibrillar forms of the protein have little or no membrane permeabilizing activity, and protofibrils of the Parkinson's disease linked mutants A30P and A53T have a higher specific permeabilizing activity per mol of protein than protofibrils of wild type. Subsequently, a random mutagenesis library of sequence variants was created which codes for approximately 1.5 million different protein sequences (estimated using a new computational method described herein), with an average of two point mutations per sequence. An in vitro aggregation screen of 70 individually expressed and purified variants from the library revealed two double-point mutants which fibrillize significantly more slowly than the wild-type protein. Future examination of the in vivo neurotoxicity of these sequence variants (in a transgenic disease model) may help elucidate the nature of Parkinson's disease pathogenesis.

ISBN: 0496654381Subjects--Topical Terms:

1017722
Chemistry, Biochemistry.

The aggregation and membrane permeabilizing activity of alpha-synuclein.
LDR:02652nmm 2200289 4500 001 1844128
005 20051017073437.5
008 130614s2004 eng d
020 $a 0496654381
035 $a (UnM)AAI3118014
035 $a AAI3118014
040 $a UnM $c UnM
100 1 $a Volles, Michael James. $3 1932331
245 1 4 $a The aggregation and membrane permeabilizing activity of alpha-synuclein.
300 $a 94 p.
500 $a Source: Dissertation Abstracts International, Volume: 65-01, Section: B, page: 0211.
500 $a Adviser: Peter T. Lansbury, Jr.
502 $a Thesis (Ph.D.)--Harvard University, 2004.
520 $a Two point mutations in the alpha-synuclein gene are genetically linked to autosomal dominant Parkinson's disease. Purified monomeric alpha-synuclein protein is unfolded in solution, but over time a small mol fraction can aggregate to form a heterogeneous mixture of beta-sheet containing soluble oligomers (termed protofibrils) which coexist with the monomeric protein. The monomer/oligomer mixture eventually proceeds to form amyloid fibrils, at which time the majority of the monomer and oligomer is consumed. It is not known which aggregation form of alpha-synuclein is neurotoxic in Parkinson's disease, nor is the pathogenic mechanism known. This thesis demonstrates that a subset of the oligomeric species are capable of permeabilizing negatively charged synthetic phospholipid vesicles via a pore-like mechanism, in vitro. The monomeric and fibrillar forms of the protein have little or no membrane permeabilizing activity, and protofibrils of the Parkinson's disease linked mutants A30P and A53T have a higher specific permeabilizing activity per mol of protein than protofibrils of wild type. Subsequently, a random mutagenesis library of sequence variants was created which codes for approximately 1.5 million different protein sequences (estimated using a new computational method described herein), with an average of two point mutations per sequence. An in vitro aggregation screen of 70 individually expressed and purified variants from the library revealed two double-point mutants which fibrillize significantly more slowly than the wild-type protein. Future examination of the in vivo neurotoxicity of these sequence variants (in a transgenic disease model) may help elucidate the nature of Parkinson's disease pathogenesis.
590 $a School code: 0084.
650 4 $a Chemistry, Biochemistry. $3 1017722
650 4 $a Biology, Molecular. $3 1017719
650 4 $a Health Sciences, Pathology. $3 1017854
690 $a 0487
690 $a 0307
690 $a 0571
710 2 0 $a Harvard University. $3 528741
773 0 $t Dissertation Abstracts International $g 65-01B.
790 1 0 $a Lansbury, Peter T., Jr., $e advisor
790 $a 0084
791 $a Ph.D.
792 $a 2004
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3118014